← FDA Drug Approvals (Drugs@FDA)

CAMZYOS

NDA · New Drug Application · Sponsor: BRISTOL · Approved 2022-04-28

Drug application

FDA Application #

NDA214998

Application type

New Drug Application

Brand name

CAMZYOS

Generic name

MAVACAMTEN

Active ingredients

MAVACAMTEN

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

BRISTOL

Manufacturer

Myokardia, Inc.

First approval

2022-04-28

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown